AIML Innovations Restructures Leadership for Strategic Growth

AI/ML Innovations Inc. has announced significant changes in its Board of Directors as it embarks on a new phase of growth and commercialization. CEO Paul Duffy and President Peter Kendall have been appointed to the Board, with Duffy also becoming Executive Chairman. This leadership realignment aims to align the company more closely with its commercial execution and market penetration goals.

Outgoing Executive Chair Mark Orsmond and Michael Nemirow will continue their involvement with AIML as strategic advisors, contributing to corporate development, partnerships, and commercialization strategies. The company remains focused on delivering innovative AI-driven healthcare technologies.

These changes reflect AIML's dedication to enhancing its industry experience and driving shareholder value. As the company advances its portfolio, it seeks to reinforce its mission at the intersection of AI and human health.